Cleared Traditional

K260687 - VivaChek Blood Glucose and ß-Ketone Dual BLE Monitoring System

Also marketed or referenced as:
VivaChek Blood Glucose and ß-Ketone Dual Monitoring System.

K260687 is an FDA 510(k) clearance for VivaChek Blood Glucose and ß-Ketone Dua..., manufactured by Vivachek Biotech (Hangzhou) Co., Ltd.. The device is a Class 2 Chemistry device with product code NBW cleared through the Traditional 510(k) pathway after a 220-day FDA review.

K260687 · Vivachek Biotech (Hangzhou) Co., Ltd. · Chemistry device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Oct 2026
Decision
220d
Days
Class 2
Risk

K260687 is an FDA 510(k) clearance for the VivaChek Blood Glucose and ß-Ketone Dual BLE Monitoring System. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Vivachek Biotech (Hangzhou) Co., Ltd. (Hangzhou, CN). The FDA issued a Cleared decision on October 9, 2026 after a review of 220 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K260687

510(k) Number K260687 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 03, 2026
Decision Date October 09, 2026
Days to Decision 220 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
131d slower than avg
Panel avg: 89d · This submission: 220d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

NBW Device Classification - Class 2, Special Controls

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 513
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K260687.
Safe AQ Easy Blood Glucose Monitoring System
K260738 · Changsha Sinocare, Inc. · Oct 2026
EASYMAX Voice Blood Glucose Monitoring System
K261293 · Eps Bio Technology Corp. · Oct 2026
CVS Advanced PLUS Blood Glucose Monitoring System
K260689 · I-Sens, Inc. · Oct 2026
CONTOUR® PLUS BLUE Blood Glucose Monitoring System
K260545 · Ascensia Diabetes Care · Aug 2026
TRUE METRIX Self Monitoring Blood Glucose System
K262116 · Trividia Health, Inc. · Jul 2026
On Call® Sure GK Blood Glucose & Ketone Monitoring System
K250085 · ACON Laboratories, Inc. · Oct 2025
K260687 · VivaChek Blood Glucose and ß-Ketone Dual BLE Monitoring System
Download PDF FDA Summary Vivachek Biotech (Han…